Native kidney post-transplant lymphoproliferative disorder in a non-renal transplant patient

Keyphrases

• Renal Transplant Recipients 100%
• Post-transplant Lymphoproliferative Disorder 100%
• Kidney Pathology 100%
• Native Kidney 100%
• Membranous Glomerulopathy 100%
• Prednisone 50%
• Renal Disease 50%
• Viremia 50%
• Immunosuppression 50%
• Liver Transplantation 50%
• Kidney 50%
• Rituximab 50%
• Fever 50%
• Renal Transplantation 50%
• Electron-dense Deposits 50%
• Kidney Allograft 50%
• Renal Parenchyma 50%
• Lymphatics 50%
• Organ Donor 50%
• Solid Organ Transplant Recipients 50%
• Cyclophosphamide 50%
• Nephrotic-range Proteinuria 50%
• Gross Hematuria 50%
• Transplant Complications 50%
• Electron Microscopy Examination 50%
• Chronic Progressive Nephropathy 50%
• Orthotropic 50%
• Generalized Lymphadenopathy 50%
• End-stage Renal Failure 50%
• Cholestatic Hepatitis 50%
• EBV Viremia 50%
• EBV-positive 50%

Medicine and Dentistry

• Kidney Graft 100%
• Posttransplant Lymphoproliferative Disease 100%
• Epstein Barr Virus 100%
• Viremia 66%
• Membranous Glomerulonephritis 66%
• Immunosuppressive Treatment 33%
• Liver Graft 33%
• Transplantation 33%
• End Stage Renal Disease 33%
• Parenchyma 33%
• Rituximab 33%
• Lymph Duct 33%
• Electron Microscopy 33%
• Kidney Transplantation 33%
• Proteinuria 33%
• Chronic Kidney Disease 33%
• Kidney Allograft 33%
• Nephropathy 33%
• Cyclophosphamide 33%
• Prednisone 33%
• Microhematuria 33%
• Cholestatic Hepatitis 33%
• Persistent Generalized Lymphadenopathy 33%